ESPE Abstracts (2018) 89 RFC7.4

aInstitut d’Investigació Biomèdica de Girona (IDIBGI), Girona, Spain; bHospital Dr. Josep Trueta, Girona, Spain; cUniversity of Tartu, Tartu, Estonia; dInstitut de Medicina Legal (IMLC), Girona, Spain; eUniversity of Leuven, Leuven, Belgium; fInstitut de Recerca Pediàtrica Sant Joan de Déu, Barcelona, Spain


Background: Early catch-up growth, between birth and age two years, in infants born small-for-gestational-age (SGA) is a risk factor for the development of cardiometabolic diseases in adulthood. The basis and mechanisms underpinning catch-up growth in SGA newborns are unknown.

Objectives: We aimed to investigate the catch-up predictive ability of cord blood miRNAs in SGA infants.

Methods: MicroRNA PCR Human Panels were used to study the miRNA profile in umbilical cord tissue of 5 SGA infants with catch-up (SGA-CU), 5 SGA infants without catch-up (SGA-nonCU) and 5 control infants (appropriate-for-gestational-age, AGA). The miRNA with differential expression between the study groups were validated in a cohort of 64 infants (24 SGA-CU, 18 SGA-nonCU and 22 AGA) and correlated with anthropometric and metabolic parameters (weight and height gain, body composition and fat distribution) at 1 and 6 years of age.

Results: The miR-501-3p, miR-576-5p, miR-770-5p and miR-876-3p associated with increased weight, height, weight catch-up and height catch-up at 1 year of age (all P<0.05); and the miR-374b-3p, miR-548c-5p, miR-576-5p y miR-99a-5p associated with increased weight, height, waist circumference and renal fat (all P<0.05) at 6 years of age. Multivariate analysis showed that miR-576-5p was predictor of weight catch-up (β=−0.474, P=0.001; R2=19.1) and height catch-up (β=0.459, P=0.01; R2=0.652) at 1 year of age; and waist circumference (β=0.459, P=0.01; R2=0.652) and renal fat (β=0.455, P=0.03; R2=0.207) at 6 years of age. In Silico studies showed that miR-576-5p participates in the regulation of inflammatory, growth and proliferation signaling pathways.

Conclusion: miR-576-5p could be a novel biomarker for the early identification of catch-up growth in SGA infants. miR-576-5p may also contribute to the regulation of postnatal growth and influence the risk for cardiometabolic diseases associated with postnatal growth.

Volume 89

57th Annual ESPE (ESPE 2018)

Athens, Greece
27 Sep 2018 - 29 Sep 2018

European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.